AMT-191

· UniQure Biopharma B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AMT-191, covering 2025-10-23 to 2025-10-23. Get the full timeline:

Most recent: Clinical Trial Update: Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease [Phase 1, Phase 2]